Status:
COMPLETED
This Present Study Can be Used by Clinicians Who Treat Psychiatric Patients: Dentists Might Expect Xerogenic Side Effects of Specific Psychiatric Drugs Which Can Affect Dental Treatment, and the Results Can Help Psychiatrist to Choose the Less Xerogenic Psychiatric Medication
Lead Sponsor:
Semmelweis University
Conditions:
Psychiatric Disorders
Xerostomia Due to Hyposecretion of Salivary Gland
Eligibility:
All Genders
18+ years
Brief Summary
The goal of this observational study is to learn about the effects of psychiatric drug therapies on intra- and extra-oral sicca symptoms and salivation. The main question that it aims to answer is: D...
Eligibility Criteria
Inclusion
- In the psychiatric group, the inclusion criteria was taking specific psychiatric medications.
Exclusion
- In the control group the exclusion criteria was reporting any diseases and taking medicines.
Key Trial Info
Start Date :
January 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2018
Estimated Enrollment :
361 Patients enrolled
Trial Details
Trial ID
NCT06920472
Start Date
January 1 2013
End Date
January 1 2018
Last Update
May 22 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.